Department of Cardiovascular Medicine, University of Kansas Health System, Kansas City, Kansas, USA.
Department of Cardiovascular Medicine, Vanderbilt University, Nashville, Tennessee, USA.
Pacing Clin Electrophysiol. 2023 Feb;46(2):100-107. doi: 10.1111/pace.14615. Epub 2022 Nov 21.
The subcutaneous ICD (S-ICD) is a viable alternative to transvenous ICD and avoids intravascular complications in patients without a pacing indication. The outcomes of S-ICD implantation are uncertain in patients with prior sternotomy.
We aim to compare the implant techniques and outcomes with S-ICD implantation in patients with and without prior sternotomy.
Multicenter retrospective cohort study including adult patients with an S-ICD implanted between January 2014 and June 2020. Outcomes were compared between patients with and without prior sternotomy.
Among the 212 patients (49 ± 15 years old, 43% women, BMI 30 ± 8 kg/m , 68% primary prevention, 30% ischemic cardiomyopathy, LVEF median 30% IQR 25%-45%) who underwent S-ICD implantation, 47 (22%) had a prior sternotomy. There was no difference in the sensing vector (57% vs. 53% primary, p = 0.55), laterality of the S-ICD lead to the sternum (94% vs. 96% leftward, p = 0.54), or the defibrillation threshold (65 ± 1.4 J vs. 65 ± 0.8 J, p = 0.76) with versus without prior sternotomy. The frequency of 30-day complications was similar with and without prior sternotomy (n = 3/47 vs. n = 15/165, 6% vs. 9%, p = 0.56). Over a median follow-up of 28 months (IQR 10-49 months), the frequency of inappropriate shocks was similar between those with and without prior sternotomy (n = 3/47 and n = 16/165, 6% vs. 10%, p = 0.58).
Implantation of an S-ICD in patients with prior sternotomy is safe with a similar risk of 30-day complications and inappropriate ICD shocks as patients without prior sternotomy.
皮下植入式心律转复除颤器(S-ICD)是经静脉植入式心律转复除颤器的一种可行替代方法,可避免无起搏适应证患者的血管内并发症。既往行胸骨切开术的患者行 S-ICD 植入术的结果尚不确定。
我们旨在比较既往行胸骨切开术和未行胸骨切开术患者行 S-ICD 植入术的植入技术和结局。
本研究为多中心回顾性队列研究,纳入 2014 年 1 月至 2020 年 6 月期间植入 S-ICD 的成年患者。比较了既往行胸骨切开术和未行胸骨切开术患者的结局。
212 例患者(49±15 岁,43%为女性,BMI 30±8kg/m ,68%为一级预防,30%为缺血性心肌病,LVEF 中位数为 30%,IQR 25%-45%)中,47 例(22%)既往行胸骨切开术。既往行胸骨切开术和未行胸骨切开术患者的感知向量(57%vs.53%为原发性,p=0.55)、S-ICD 导线至胸骨的侧位(94%vs.96%为左侧,p=0.54)或除颤阈值(65±1.4J vs.65±0.8J,p=0.76)无差异。30 天并发症的发生率在既往行胸骨切开术和未行胸骨切开术患者中相似(n=3/47 例 vs. n=15/165 例,6%vs.9%,p=0.56)。中位随访 28 个月(IQR 10-49 个月)时,既往行胸骨切开术和未行胸骨切开术患者的不恰当电击发生率相似(n=3/47 例和 n=16/165 例,6%vs.10%,p=0.58)。
既往行胸骨切开术患者植入 S-ICD 是安全的,30 天并发症和不恰当 ICD 电击的风险与既往未行胸骨切开术患者相似。